Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials

Carmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, Giovambattista Capasso, Danilo Fliser, Denis Fouque, Dimitrios Goumenos, Markus Ketteler, Ziad Massy, Ivan Rychlık, Maria Soler, Kate Stevens, Goce Spasovski, Christoph Wanner

Research output: Contribution to journalReview articlepeer-review

Abstract

The exclusion of chronic kidney disease (CKD) patients from clinical trials-particularly cardiovascular trials-remains a long-standing, unsolved problem, which prevents the optimization of clinical care in these patients. The situation recalls the insufficient recruitment of women in cardiovascular trials until the 1980s, a problem that was only resolved following regulatory interventions. Regulatory agencies are in a unique position to promote recruitment of CKD patients in clinical trials. The main stakeholders, namely patients' associations and scientific societies, should make major lobbying efforts to persuade these agencies that the issue is an absolute public health priority.

Original languageEnglish
Pages (from-to)1112-1114
Number of pages3
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Volume34
Issue number7
Early online date27 Feb 2019
DOIs
Publication statusPublished - Jul 2019

Keywords

  • CKD
  • Cardiovascular
  • Clinical trial
  • Diabetes mellitus
  • Guidelines
  • clinical trial
  • guidelines
  • diabetes mellitus
  • cardiovascular

Fingerprint

Dive into the research topics of 'Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials'. Together they form a unique fingerprint.

Cite this